DOCSLIB.ORG

Accepted Abstracts

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Accepted Abstracts conferenceseries.com conferenceseries.com 919th Conference 6th International Conference on Cosmetology, Trichology and Aesthetic PracticesApril 13-14, 2017 Dubai, UAE Accepted Abstracts Page 39 J Clin Exp Dermatol Res 2017, 8:1 (Suppl) conferenceseries.com http://dx.doi.org/10.4172/2155-9554.C1.054 6th International Conference on Cosmetology, Trichology and Aesthetic Practices April 13-14, 2017 Dubai, UAE Management of hair loss Pragya Nair P Pramukhswami Medical College, India oss of hair is one of the commonest complaints that baffle dermatologists. Depending on whether hair follicles are Lpermanently damaged or not, hair loss from the scalp is divided into scarring and non-scarring alopecia’s. Causes of non-scarring alopecia includes congenital and hereditary disorders, telogen and anagen hair loss, hair shaft defects, alopecia totals and universalis, telogen effluvium, andogenic alopecia, alopecia areata, drugs or any systemic illness. Discoid lupus erythematous, morphea, trauma and pseudopalade of brocq are few of the causes of cicatricial alopecia. Hair evaluation methods are grouped into three main categories: Non-invasive methods (e.g., questionnaire, daily hair counts, standardized wash test, 60-s hair count, global photographs, dermoscopy, hair weight, phototrichogram, trichoScan and polarizing and surface electron microscopy), semi-invasive method involves trichogram and invasive method includes scalp biopsy. Complete blood count and routine urine examination, levels of serum ferritin and T3, T4 and TSH should be checked in all cases of diffuse hair loss. High fever, any infection or disease should be identified and treated. Patients with suspected excess androgen need hormonal assessment. Telogen effluvium does not require specific drugs as the condition is self-limiting and usually resolves in 3-6 months. Oral iron sulphate, zinc and biotin should be given in deficient cases. Drugs should be avoided which are causing hair loss. Minoxidil solution 2% and 5% is indicated for mild to moderate hair loss while Minoxidil 2% plus antiandrogens/ finestride for hair loss with hyperandrogenism. Hair prosthesis (wig, hair extension, hairpiece) and hair cosmetics (tinted powders, lotions sprays) is used for severe and recalcitrant hair loss and also as an adjuvant to medical therapy in mild to moderate cases. Ideal candidate for hair transplantation are those who have high-density donor hair (>40 follicular unit/cm2). Other therapies like PRP (Platelet Rich Plasma) and meso therapy have also been used with good results. [email protected] Fractional CO2 laser versus intense pulsed light in treating striae distensae Moustafa Adam El Taieb1 and Ahmed Khair Ibrahim2 1Aswan University, Egypt 2Assiut University, Egypt Background: Striae distensae are linear atrophic dermal scars covered with flat atrophic epidermis. They cause disfigurement, especially in females. Many factors may cause striae distensae such as steroids, obesity and pregnancy. Although there is no standard treatment for striae, many topical applications, peeling, light and laser systems have been tried. Aims: This study aims to evaluate and compare the efficacy of fractional2 CO laser with intense pulse light in treating striae distensae. Subjects & Methods: Forty patients with striae distensae were recruited. Twenty of them were treated by fractional CO2 laser and 20 were treated with intense pulse light. Length and width of the largest striae were measured pre and post treatment. Patient satisfaction was also evaluated and graded. Patients were photographed after each treatment session and photos were examined by a blinded physician who had no knowledge about the cases. Results: Both groups showed significant improvement after treatments (P<0.05). Patients treated with fractional CO2 laser showed significant improvement after the fifth session compared with those treated with ten sessions of intense pulsed light (P<0.05) in all parameters except in the length of striae (P>0.05). Conclusion: Fractional CO2 laser was found to be more effective in treatment of striae distensae. [email protected] J Clin Exp Dermatol Res Volume 8, Issue 1 (Suppl) ISSN: 2155-9554 JCEDR, an open access journal Cosmetology 2017 April 13-14, 2017 Page 40 J Clin Exp Dermatol Res 2017, 8:1 (Suppl) conferenceseries.com http://dx.doi.org/10.4172/2155-9554.C1.054 6th International Conference on Cosmetology, Trichology and Aesthetic Practices April 13-14, 2017 Dubai, UAE Micro needling: A form of collagen induction therapy for acne scars Pragya Nair Shree Krishna Hospital, India cne Vulgaris (AV) is the most common skin disease affecting adolescent and young adults with reported prevalence of Anearly 80%, characterized by comedones, papules, pustules and nodules involving face, upper back, chest and upper arms. Furthermore, it causes permanent scarring which is difficult to treat. AV has a psychological impact on patient, regardless of the severity or grade of the disease. It cause long-lasting and detrimental psychosocial effects and is associated with depression and anxiety. Acne scars are graded broadly, as atrophic and hypertrophic. Atrophic acne scars have been further classified as icepick, rolling and box scar. Micro needling, a form of collagen induction therapy using a device called derma roller is used as a treatment modality for acne scars. Micro needling is effective in grade 2 and 3 rolling/box car scars with good to excellent response and moderate response is seen in pitted scars. Micro needling aims to stimulate collagen production by producing micro wounds and initiating the normal post-inflammatory chemical cascade. Collagen fiber bundles qualitatively increase, thickens and are more loosely woven in both papillary and reticular dermis. It lays down in normal lattice pattern than in parallel bundles as in scar tissue. Neovascularization and neocollagenesis also occurs following treatment which leads to reduction of scars. This technique is easy to master. It has a short healing time and can be used in any type of skin where lasers and deep peels cannot be performed. No risk of post inflammatory hyperpigmentation is evidenced. It can be combined with other acne scar treatment like subcision, chemical peeling, microdermabrasion and fractional resurfacing and maximum benefits can be achieved. [email protected] Aesthetic rhinoplasty - Primary and secondary: How I do it? Hamid Karimi Iran University of Medical Sciences, Iran hinoplasty is a very frequent aesthetic procedure in my country. During this presentation, I will explain my techniques and Rmethods for primary and secondary rhinoplasties. Several methods for correction of secondary nasal obstruction will be discussed with video presentation. At the end, results of methods for treatment of nasal obstruction will be presented. Nasal obstruction is a very omnius complication of the aesthetic rhinoplasty. In our country, more than 600 rhinoplasty surgeries are performed every day. One of the frequent complications of these surgeries is nasal obstruction. Internal Nasal Valve (INV) is the narrowest point in nasal airway and thus is the controlling point which regulates inspiration flow. Cross-section area of INV is about 40-55 mm and 40-50% of inspiratory resistance is due to INV function. Collapse of one or both INV can be a consequence of previous surgery, trauma, aging, or primary weakness of upper lateral cartilage. In this study, autologous conchal cartilage was used as a butterfly graft for opening and reconstruction of INV and the results were compared with spreader graft or spreader flap. All of the patients with secondary nasal obstruction in past 6 years in our office and clinic were included. Inclusion on criteria was positive Cottle and modified Cottle sign. And nasal function was studied before and after treatment. The results were compared with results of spreader graft and spreader flap. During more than 6 years, 41 patients (28 female and 13 male) were operated using butterfly graft and 94 patients were treated with spreader graft and 79 patients with spreader flap. In butterfly graft group, etiology of collapse was previous surgery in 22 patients (53.6%), primary weakness in 10 patients (24.3%) and nasal trauma in 9 patients (21.9%). After 10-40 months follow up, 96% of patients had good to excellent (stable) subjective respiratory function. The results of butterfly graft were similar to spreader grafts and flaps. There was no major morbidity or complication with butterfly graft after surgery. Six patients complained of broadening in middle vault. The butterfly graft for secondary nasal obstruction has the same results as spreader graft or flap. [email protected] J Clin Exp Dermatol Res Volume 8, Issue 1 (Suppl) ISSN: 2155-9554 JCEDR, an open access journal Cosmetology 2017 April 13-14, 2017 Page 41 J Clin Exp Dermatol Res 2017, 8:1 (Suppl) conferenceseries.com http://dx.doi.org/10.4172/2155-9554.C1.054 6th International Conference on Cosmetology, Trichology and Aesthetic Practices April 13-14, 2017 Dubai, UAE Aging and volumes of the midface: New strategy of volumization Sergey Prokudin Rostov State Medical University, Russia he ageing of the middle third of the face has its individual peculiarities and regularities. Based on sections of cadaveric Tmaterial (23 heads), a retrospective analysis of a group of patients (70 people), we have developed a classification based on time of occurrence of volume changes in deep and superficial compartments of the middle third of the face. The
Load more

Recommended publications
  • Dissecting Cellulitis
    Patient Information Leaflet Dr Paul Farrant FRCP Consultant Dermatologist Janet Dix (Secretary to Dr Paul Farrant) Tel 01444 412273 Fax 01444 657397 Email [email protected] Web drpaulfarrant.co.uk Dissecting Cellulitis What is dissecting cellulitis? Dissecting cellulitis is a type of scarring hair loss that presents with pustules, boggy swellings, and sinuses within the scalp. What causes dissecting cellulitis? The cause of dissecting cellulitis is not known. It is associated with severe cystic acne known as acne conglobata, and hidradenitis suppurativa, which causes cystic swellings in the armpits and groin. In all of these conditions the hair follicle becomes blocked, dilates and ruptures. This causes an inflammatory response in the skin, which leads to pus formation, swellings and sinus formation. It is not uncommon for bacteria to be isolated from the skin but this is likely to be secondary to the inflammatory process. Is dissecting cellulitis inherited? Dissecting cellulitis is most commonly seen in Afro-Caribbean men but the racial predilection is more likely to be due to the shape and structural differences of Afro-Caribbean hair than a genetic predisposition to the condition. Hair care practices, such as clipping, may also play a role. It is not thought to be an inherited condition. What are the symptoms? Patients with dissecting cellulitis often complain of pain, tenderness and fluid discharge from the affected area. It is associated with hair loss. What does dissecting cellulitis look like? Dissecting Cellulitis is characterised by a localised area of hair loss, pustules, boggy swellings and sinus formation. Gentle pressure on the boggy areas may lead to expression of pus or serous fluid.
    [Show full text]
  • Guidelines of Care for the 10 Most Common Dermatologic Diseases
    1 Guidelines of Care for the 10 most common dermatologic diseases: Copyright by the American Academy of Dermatology, Inc. Disclaimer Adherence to these guidelines will not ensure successful treatment in every situation. Further, these guidelines should not be deemed inclusive of all proper methods of care or exclusive of other methods of care reasonably directed to obtaining the same results. The ultimate judgment regarding the propriety of any specific procedure must be made by the physician in light of all the circumstances presented by the individual patient. For the benefit of members of the American Academy of Dermatology who practice in countries outside the jurisdiction of the United States, the listed treatments may include agents that not currently approved by the U.S. Food and Drug Administration. 1. Acne Vulgaris 2. Alopecia Areata 3. Atopic Dermatitis 4. Contact Dermatitis 5. Cutaneous Adverse Drug Reactions 6. Nail Disorders 7. Psoriasis 8. Superficial Mycotic Infections of the Skin: Mucocutaneous Candidiasis, Onychomycosis, Piedra, Pityriasis, Tinea Capitis , Tinea Barbae, Tinea Corporis, Tinea Cruris, Tinea Faciei, Tinea Manuum, and Tinea Pedis. 9. Vitiligo 10. Warts: Human Papillomavirus 1 2 1- Guidelines of Care for Acne Vulgaris* Reference: 1990 by the American Academy of Dermatology, Inc. I. Introduction The American Academy of Dermatology’s Committee on Guidelines of Care is developing guidelines of care for our profession. The development of guidelines will promote the continued delivery of quality care and assist those outside our profession in understanding the complexities and boundaries of care provided by dermatologists. II. Definition Acne vulgaris is a follicular disorder that affects susceptible pilosebaceous follicles, primarily of the face, neck, and upper trunk, and is characterized by both noninflammatory and inflammatory lesions.
    [Show full text]
  • Pediatric and Adolescent Dermatology
    Pediatric and adolescent dermatology Management and referral guidelines ICD-10 guide • Acne: L70.0 acne vulgaris; L70.1 acne conglobata; • Molluscum contagiosum: B08.1 L70.4 infantile acne; L70.5 acne excoriae; L70.8 • Nevi (moles): Start with D22 and rest depends other acne; or L70.9 acne unspecified on site • Alopecia areata: L63 alopecia; L63.0 alopecia • Onychomycosis (nail fungus): B35.1 (capitis) totalis; L63.1 alopecia universalis; L63.8 other alopecia areata; or L63.9 alopecia areata • Psoriasis: L40.0 plaque; L40.1 generalized unspecified pustular psoriasis; L40.3 palmoplantar pustulosis; L40.4 guttate; L40.54 psoriatic juvenile • Atopic dermatitis (eczema): L20.82 flexural; arthropathy; L40.8 other psoriasis; or L40.9 L20.83 infantile; L20.89 other atopic dermatitis; or psoriasis unspecified L20.9 atopic dermatitis unspecified • Scabies: B86 • Hemangioma of infancy: D18 hemangioma and lymphangioma any site; D18.0 hemangioma; • Seborrheic dermatitis: L21.0 capitis; L21.1 infantile; D18.00 hemangioma unspecified site; D18.01 L21.8 other seborrheic dermatitis; or L21.9 hemangioma of skin and subcutaneous tissue; seborrheic dermatitis unspecified D18.02 hemangioma of intracranial structures; • Tinea capitis: B35.0 D18.03 hemangioma of intraabdominal structures; or D18.09 hemangioma of other sites • Tinea versicolor: B36.0 • Hyperhidrosis: R61 generalized hyperhidrosis; • Vitiligo: L80 L74.5 focal hyperhidrosis; L74.51 primary focal • Warts: B07.0 verruca plantaris; B07.8 verruca hyperhidrosis, rest depends on site; L74.52 vulgaris (common warts); B07.9 viral wart secondary focal hyperhidrosis unspecified; or A63.0 anogenital warts • Keratosis pilaris: L85.8 other specified epidermal thickening 1 Acne Treatment basics • Tretinoin 0.025% or 0.05% cream • Education: Medications often take weeks to work AND and the patient’s skin may get “worse” (dry and red) • Clindamycin-benzoyl peroxide 1%-5% gel in the before it gets better.
    [Show full text]
  • Early Diagnosis and Treatment of Discoid Lupus Erythematosus
    J Am Board Fam Med: first published as 10.3122/jabfm.2009.02.080075 on 5 March 2009. Downloaded from BRIEF REPORT Early Diagnosis and Treatment of Discoid Lupus Erythematosus Suresh Panjwani, MD, MSc, FRACGP Discoid lupus erythematosus is a chronic dermatological disease that can lead to scarring, hair loss, and hyperpigmentation changes in skin if it is not treated early and promptly. It has a prolonged course and can have a considerable effect on quality of life. Early recognition and treatment improves the prog- nosis. The diagnosis is usually made by clinical examination. In some cases histopathology may be re- quired to confirm the diagnosis. The histology is that of an inflammatory interface dermatosis. There is insufficient evidence for which treatment is most effective. Because lesions are induced or exacerbated by ultraviolet exposure, photoprotective measures are important. Potent topical steroids and antima- larials are the mainstay of treatment. Some cases of discoid lupus erythematosus can be refractory to standard therapy; in these cases retinoids, thalidomide, and topical tacrolimus offer alternatives, as do immunosuppressives like azathioprine, cyclosporine, mycophenolate mofetil, and methotrexate. (J Am Board Fam Med 2009;22:206–213.) Lupus erythematosus (LE) is thought to be an 5% of patients with discoid lupus may develop autoimmune disease among other connective tissue SLE1 and 25% of patients with SLE may develop diseases like scleroderma, rheumatoid arthritis, typical chronic discoid lesions at some time during copyright.
    [Show full text]
  • Case of Persistent Regrowth of Blond Hair in a Previously Brunette Alopecia Areata Totalis Patient
    Case of Persistent Regrowth of Blond Hair in a Previously Brunette Alopecia Areata Totalis Patient Karla Snider, DO,* John Young, MD** *PGYIII, Silver Falls Dermatology/Western University, Salem, OR **Program Director, Dermatology Residency Program, Silver Falls Dermatology, Salem, OR Abstract We present a case of a brunette, 64-year-old female with no previous history of alopecia areata who presented to our clinic with diffuse hair loss over the scalp. She was treated with triamcinolone acetonide intralesional injections and experienced hair re-growth of initially white hair that then partially re-pigmented to blond at the vertex. Two years following initiation of therapy, she continued to have blond hair growth on her scalp with no dark hair re-growth and no recurrence of alopecia areata. Introduction (CBC), comprehensive metabolic panel (CMP), along the periphery of the occipital, parietal and Alopecia areata (AA) is a fairly common thyroid stimulating hormone (TSH) test and temporal scalp), sisaipho pattern (loss of hair in autoimmune disorder of non-scarring hair loss. antinuclear antibody (ANA) test. All values were the frontal parietotemporal scalp), patchy hair unremarkable, and the ANA was negative. The loss (reticular variant) and a diffuse thinning The disease commonly presents as hair loss from 2 any hair-bearing area of the body. Following patient declined a biopsy. variant. Often, “exclamation point hairs” can be hair loss, it is not rare to see initial growth of A clinical diagnosis of alopecia areata was seen in and around the margins of the hair loss. depigmented or hypopigmented hair in areas made. The patient was treated with 5.0 mg/mL The distal ends of these hairs are thicker than the proximal ends, and they are a marker of active of regrowth in the first anagen cycle.
    [Show full text]
  • A Practical Approach to the Diagnosis and Management of Hair Loss in Children and Adolescents
    A Practical Approach to the Diagnosis and Management of Hair Loss in Children and Adolescents The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citation Xu, Liwen, Kevin X. Liu, and Maryanne M. Senna. 2017. “A Practical Approach to the Diagnosis and Management of Hair Loss in Children and Adolescents.” Frontiers in Medicine 4 (1): 112. doi:10.3389/ fmed.2017.00112. http://dx.doi.org/10.3389/fmed.2017.00112. Published Version doi:10.3389/fmed.2017.00112 Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:34375289 Terms of Use This article was downloaded from Harvard University’s DASH repository, and is made available under the terms and conditions applicable to Other Posted Material, as set forth at http:// nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use#LAA REVIEW published: 24 July 2017 doi: 10.3389/fmed.2017.00112 A Practical Approach to the Diagnosis and Management of Hair Loss in Children and Adolescents Liwen Xu1†, Kevin X. Liu1† and Maryanne M. Senna2* 1 Harvard Medical School, Boston, MA, United States, 2 Department of Dermatology, Massachusetts General Hospital, Boston, MA, United States Hair loss or alopecia is a common and distressing clinical complaint in the primary care setting and can arise from heterogeneous etiologies. In the pediatric population, hair loss often presents with patterns that are different from that of their adult counterparts. Given the psychosocial complications that may arise from pediatric alopecia, prompt diagnosis and management is particularly important. Common causes of alopecia in children and adolescents include alopecia areata, tinea capitis, androgenetic alopecia, traction Edited by: alopecia, trichotillomania, hair cycle disturbances, and congenital alopecia conditions.
    [Show full text]
  • Dissecting Cellulitis of the Scalp
    Dissecting Cellulitis of the Scalp What is Dissecting Cellulitis of the Scalp? Dissecting cellulitis of the scalp is a rare condition in which pus-filled lumps develop on the scalp, resulting in scarring and permanent hair loss over the area affected. What causes it? The cause is unknown, although it is most likely due to blocked and ruptured hair follicles, resulting in significant inflammation and secondary bacterial infection. What does it look like? The appearance of dissecting cellulitis of the scalp is that of pus-filled lumps and nodules on the scalp with overlying scarring and hair loss. Habif’s Clinical Dermatology – A Color Guide to Diagnosis and Therapy SEVENTH EDITION, James G.H. Dinulos, MD 2020 © Australasian College of Dermatologists. You may use for personal use only. Please refer to our disclaimer. Habif’s Clinical Dermatology – A Color Guide to Diagnosis and Therapy SEVENTH EDITION, James G.H. Dinulos, MD What other problems can occur with the condition? Other conditions related to hair follicle blockage, rupture and inflammation can occur with dissecting cellulitis of the scalp. They are known as the “follicular occlusion tetrad” and include acne conglobata (a severe form of acne), hidradenitis suppurativa (boils and cysts in the body folds) and pilonidal sinus (an infected cyst at the base of the spine). In addition, inflammation of the joints (arthritis) and bones can rarely occur in association with these conditions. How is it diagnosed? The condition can usually be diagnosed by clinical appearance by a dermatologist examining the scalp. Swabs of pus and plucked hairs can be analysed to rule out infections.
    [Show full text]
  • Hair Loss in Women
    T h e new england journal o f medicine clinical practice Hair Loss in Women Jerry Shapiro, M.D. This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they exist. The article ends with the author’s clinical recommendations. A 45-year-old white woman presents with a 1-year history of scalp-hair loss. She was hospitalized with appendicitis 14 months ago. She has been a vegetarian for 20 years. She takes no medications. Her father was bald. On physical examination, she has dif- fuse, nonscarring hair thinning with a widened part over the central portion of the scalp. How should this problem be evaluated and treated? The Clinical Problem From the Department of Dermatology Hair loss, or alopecia, is a very common presenting symptom, and more than one and Skin Science, University of British third of women have clinically significant hair loss during their lifetime. The effect Columbia, and Vancouver Coastal Health Research Institute — both in Vancouver, of hair loss on patients’ emotions is often greatly underestimated by physicians. Canada; and the Department of Derma- After bone marrow, hair is the second fastest growing tissue of the body. As a re- tology, New York University, New York. sult, many metabolic derangements can be manifested with alopecia, and hair loss Address reprint requests to Dr. Shapiro at the Department of Dermatology and may be the first clinical sign of systemic disease. Skin Science, University of British Co- lumbia, 835 W.
    [Show full text]
  • Phototherapy, Photochemotherapy, and Excimer Laser Therapy for Dermatologic Conditions
    Medical Coverage Policy Effective Date ............................................. 9/15/2021 Next Review Date ....................................... 9/15/2022 Coverage Policy Number .................................. 0031 Phototherapy, Photochemotherapy, and Excimer Laser Therapy for Dermatologic Conditions Table of Contents Related Coverage Resources Overview .............................................................. 1 Extracorporeal Photopheresis Coverage Policy ................................................... 1 General Background ............................................ 4 Medicare Coverage Determinations .................. 17 Coding/Billing Information .................................. 17 References ........................................................ 18 INSTRUCTIONS FOR USE The following Coverage Policy applies to health benefit plans administered by Cigna Companies. Certain Cigna Companies and/or lines of business only provide utilization review services to clients and do not make coverage determinations. References to standard benefit plan language and coverage determinations do not apply to those clients. Coverage Policies are intended to provide guidance in interpreting certain standard benefit plans administered by Cigna Companies. Please note, the terms of a customer’s particular benefit plan document [Group Service Agreement, Evidence of Coverage, Certificate of Coverage, Summary Plan Description (SPD) or similar plan document] may differ significantly from the standard benefit plans upon which these Coverage
    [Show full text]
  • Alopecias in Lupus Erythematosus
    Review Lupus Sci Med: first published as 10.1136/lupus-2018-000291 on 25 October 2018. Downloaded from Alopecias in lupus erythematosus Josef Symon Salgado Concha,1,2 Victoria P Werth1,2 To cite: Concha JSS, ABSTRACT of the hair in the absence of other causes.1 Werth VP. Alopecias in Several patterns of hair loss can occur in lupus Several processes that result in non-scarring lupus erythematosus. erythematosus (LE). Alopecias which show histological alopecia must therefore be ruled out before Lupus Science & Medicine characteristics of LE are LE-specific, and include discoid 2018;5:e000291. doi:10.1136/ attributing hair loss to LE (boxes 1 and 2). LE (DLE), diffuse or patchy hair loss in acute LE, subacute lupus-2018-000291 In this paper, we discuss an approach to cutaneous LE, and rarely tumid LE. Lupus hair in SLE is a recognising the different causes of hair loss poorly characterised entity and may be a form of telogen that occur in LE and their differential diag- Received 4 July 2018 effluvium. Alopecia areata can coexist with LE and may Revised 15 August 2018 mimic DLE. Non-lupus alopecias such as telogen effluvium noses. The categorisation we employ is largely Accepted 2 September 2018 and anagen effluvium have a myriad of causes which based on how scalp biopsy features are consis- include disease flares, drugs and stress in the setting tent with the diagnosis of LE. We also expand of LE. The latest validated Systemic Lupus International on the alternate diagnoses of non-scarring Collaborating Clinics classification criteria for SLE includes alopecia in LE.
    [Show full text]
  • Scholars Journal of Medical Case Reports Alopecia Due to Demodexis
    Akbarijo M et al.; Sch J Med Case Rep, September 2015; 3(9A):806-808 Scholars Journal of Medical Case Reports ISSN 2347-6559 (Online) Sch J Med Case Rep 2015; 3(9A):806-808 ISSN 2347-9507 (Print) ©Scholars Academic and Scientific Publishers (SAS Publishers) (An International Publisher for Academic and Scientific Resources) Alopecia due to demodexis M Akbarijo1, F Hashemi2, R Daie3, SJ Hashemi4* 1MSC microbiology, Tonekabon Branch, Tonekabon, Iran 2Student of school of pharmacy, Tehran University of Medical Sciences, Tehran, Iran 3,4Department of Medical Mycology, School of Public Health Research, Tehran University of Medical Sciences, Tehran, Iran *Corresponding author SJ Hashemi Email: [email protected] Abstract: Demodex is a common commensal mite of the pilosebaceous unit in human and animal (mammals). Alopecia is a loss of hair from the head or body and there are many type of hair loss with different symptoms and causes. This is a case report of a 30-year-old woman with hairless area in head. She had no families’ history of alopecia or autoimmune disease. There was no significant improvement after 1 year routine treatment for her alopecia. She had a domestic pet (Hamster) and she announced that her hamster has slept in her bedroom (her bed). We taken scales from hairless area and examined it under microscope and the hamster skin was also examined. In microscopic direct examination of her scalp observed many demodex in two species D. folliculorum and D. cricetuli and only D. cricetuli in her hamster. She was treated for demodexis and after about 2 months her hair re grown.
    [Show full text]
  • ICD-10-CM TABULAR LIST of DISEASES and INJURIES
    K95.09 Other complications of gastric band procedure Use additional code, if applicable, to further specify complication K95.8 Complications of other bariatric procedure Excludes1: complications of gastric band surgery (K95.0-) K95.81 Infection due to other bariatric procedure Use additional code to specify type of infection or organism, such as: bacterial and viral infectious agents (B95.-, B96.-) cellulitis of abdominal wall (L03.311) sepsis (A40.-, A41.-) K95.89 Other complications of other bariatric procedure Use additional code, if applicable, to further specify complication Chapter 12 Diseases of the skin and subcutaneous tissue (L00-L99) Excludes2: certain conditions originating in the perinatal period (P04-P96) certain infectious and parasitic diseases (A00-B99) complications of pregnancy, childbirth and the puerperium (O00-O9A) congenital malformations, deformations, and chromosomal abnormalities (Q00-Q99) endocrine, nutritional and metabolic diseases (E00-E88) lipomelanotic reticulosis (I89.8) neoplasms (C00-D49) symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94) systemic connective tissue disorders (M30-M36) viral warts (B07.-) This chapter contains the following blocks: L00-L08 Infections of the skin and subcutaneous tissue L10-L14 Bullous disorders L20-L30 Dermatitis and eczema L40-L45 Papulosquamous disorders L49-L54 Urticaria and erythema L55-L59 Radiation-related disorders of the skin and subcutaneous tissue L60-L75 Disorders of skin appendages L76 Intraoperative and postprocedural
    [Show full text]